| DRAVP ID |
Name |
Sequence |
Target Organism |
Pubmed/Patent ID |
| DRAVPe01393 |
UL54(1221-1242) |
LPRRLHLEPAFLPYSVKAHECC |
HCMV |
12857903 |
| DRAVPe01394 |
UL54(1206-1225) |
PGGETARKDKFLHMVLPRRL |
HCMV |
12857903 |
| DRAVPe01395 |
UL54(1191-1210) |
EQVLKAVTNVLSPVFPGGET |
HCMV |
12857903 |
| DRAVPe01396 |
UL54(1176-1195) |
YVREHGVPIHADKYFEQVLK |
HCMV |
12857903 |
| DRAVPe01397 |
UL54(1161-1180) |
PPSAVCNYEVAEDPSYVREH |
HCMV |
12857903 |
| DRAVPe01398 |
UL54(1223-1242) |
RRLHLEPAFLPYSVKAHECC |
HCMV |
12857903 |
| DRAVPe01399 |
UL54(1221-1241) |
LPRRLHLEPAFLPYSVKAHEC |
HCMV |
12857903 |
| DRAVPe01400 |
UL54(1221-1240) |
LPRRLHLEPAFLPYSVKAHE |
HCMV |
12857903 |
| DRAVPe01468 |
A4 |
SSCNMGWDTPACCVWFPYWV |
HCMV |
19740994 |
| DRAVPe01469 |
A8 |
MAVGLVLCDWWLGEYLLEA |
HCMV |
19740994 |
| DRAVPe01470 |
A56 |
PVLQPALSLSCGPEPLLLSC |
HCMV |
19740994 |
| DRAVPe01471 |
A110 |
IEVTFVNRRGDGAELWYLSA |
HCMV |
19740994 |
| DRAVPe01653 |
Peptide 2 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
| DRAVPe01654 |
Peptide 3 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
| DRAVPe01655 |
Peptide 4 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
| DRAVPe01656 |
Peptide 5 |
GVLVQ |
SARS-CoV-2,HCMV,VZV |
34502335 |
| DRAVPe01657 |
Peptide 6 |
GVLV |
SARS-CoV-2,HCMV,VZV |
34502335 |
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.